Cosmetic cross-reference

Benzododecinium Chloride

CAS 139-07-1

Benzododecinium Chloride (CAS 139-07-1) is a Phase 2 pharmaceutical compound with 2 bioactivity targets and 727 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
2
SOURCE DrugCentral
Adverse signals
727
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Benzododecinium Chloride
CAS Number
139-07-1
UNII
Y5A751G47H
InChIKey
JBIROUFYLSSYDX-UHFFFAOYSA-M
ChEMBL ID
CHEMBL1885899
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 2
Mid-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL1885899 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- MIC 27750 nM 8 -
- Potency 15078.066666666668 nM 3 -
SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Completed suicide 4163 6211.769 10010144
Drug abuse 3357 5440.77 10013654
Toxicity to various agents 5028 5421.588 10070863
Cardio-respiratory arrest 1227 1292.663 10007617
Intentional overdose 1209 1211.046 10022523
Overdose 1489 1012.306 10033295
Alcohol interaction 306 798.755 10001597
Cardiac arrest 1190 763.748 10007515
Local anaesthetic systemic toxicity 194 687.263 10082534
Suicide attempt 791 637.616 10042464
Suspected suicide 324 607.462 10082458
Methaemoglobinaemia 263 602.539 10027496
Alcohol abuse 268 597.975 10001584
Intentional product misuse 752 541.348 10074903
Alcohol poisoning 212 466.465 10001605
Respiratory arrest 480 393.494 10038669
Toxic anterior segment syndrome 141 327.382 10066366
Exposure to toxic agent 183 304.682 10053487
Substance abuse 209 301.419 10066169
Coma 593 293.906 10010071
Pemphigus 12 278.035 10034280
Respiratory depression 287 264.595 10038678
Drug dependence 354 262.785 10013663
Alcohol use 140 256.574 10048921
Death 2137 243.619 10011906
Hand deformity 10 243.418 10061194
Glossodynia 21 242.821 10018388
Systemic lupus erythematosus 41 241.548 10042945
Anaesthetic complication 110 230.227 10060938
Synovitis 36 226.4 10042868
Diarrhoea 954 224.585 10012735
Sinusitis 927 214.483 10040753
Anaphylactic reaction 486 213.113 10002198
Abdominal discomfort 194 212.292 10000059
Alopecia 181 210.032 10001760
Poisoning deliberate 195 197.11 10036000
Infusion site pain 199 194.124 10053483
Mydriasis 190 186.71 10028521
Anaphylactic shock 265 179.04 10002199
Drug intolerance 219 176.012 10061822
Tachycardia 713 175.355 10043071
Anti-cyclic citrullinated peptide antibody positive 7 175.185 10068798
Hypotension 1365 174.99 10021097
Pericarditis 23 171.112 10034484
Contraindicated product administered 107 170.724 10078504
Generalised tonic-clonic seizure 291 168.286 10018100
Infusion site swelling 141 159.904 10053505
Infusion site extravasation 160 159.755 10064774
Asphyxia 144 153.07 10003497
Rash 702 151.586 10037844

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
BENZODODECINIUM CHLORIDE 1311592 SU MTHSPL
benzododecinium chloride 1311592 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Benzododecinium Chloride used for in pharmaceutical contexts?

Benzododecinium Chloride (CAS 139-07-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Benzododecinium Chloride?

Benzododecinium Chloride has 727 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Completed suicide, Drug abuse, Toxicity to various agents, Cardio-respiratory arrest, Intentional overdose. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Benzododecinium Chloride also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Lauralkonium Chloride with EU status "permitted".

What clinical phase is Benzododecinium Chloride in?

Benzododecinium Chloride is rendered with ChEMBL max phase 2.